MedicaidPrior AuthMedium impact
Provider Letter 2026-09: RE: Prior Authorization Nyvepria™ - Effective June 15, 2026
Oklahoma SoonerCare·OK · Oncology, Hematology·Prior Authorization
Effective date
Jun 15, 2026
We identified it
Jun 20, 2026
Summary
Oklahoma Medicaid will require prior authorization for Nyvepria™ (pegfilgrastim-apgf) effective June 15, 2026. Six other pegfilgrastim products remain preferred and do not require prior authorization, including Neulasta® and Fulphila®.
Action Required
By June 15, 2026: Billing team must update prior authorization workflows to require PA for Nyvepria™ (pegfilgrastim-apgf) for Oklahoma Medicaid patients. Use Form PHARM-208 and submit to Pharmacy Prior Authorization Unit via fax. Update encounter forms to alert providers that six alternative pegfilgrastim products (Fulphila®, Fylnetra®, Neulasta®, Neulasta® Onpro®, Udenyca®, Ziextenzo®) remain preferred without PA requirements.